February 19, 2015

Olivier Brandicourt to leave Bayer HealthCare

Leverkusen, February 19, 2015 - Effective March 31, 2015, Olivier Brandicourt
(59), Chairman of the Board of Management of Bayer HealthCare AG and member of
the Executive Council of Bayer AG, will leave the company to become new CEO of
Sanofi as of April 2, 2015. On the same date, Werner Baumann (52), member of
the Board of Management of Bayer AG, will take over the function of Chairman at
Bayer HealthCare.

Baumann will remain a member of the Board of Management of Bayer AG and of the
company's Executive Council. He will also retain responsibility for strategy
and portfolio management as well as for the Europe region. He already held
leading positions at Bayer HealthCare from 2002 to 2009 - initially as Head of
Central Administration & Organization and later as a member of the Board of
Management and as the subgroup's Labor Director. Between 2006 and 2009, he
actively participated in the integration of Schering AG, Berlin, Germany. Bayer
HealthCare comprises the Pharmaceuticals, Consumer Care, Animal Health and
Medical Care divisions.

"I would like to thank Olivier Brandicourt for his commitment and his
contributions to the very successful development of Bayer HealthCare and I wish
him all the best in his new function as CEO of Sanofi," said Dr. Marijn
Dekkers, Chairman of the Board of Management of Bayer AG. "At the same time, I
am very pleased that Werner Baumann will be leading our HealthCare business. He
is a highly experienced leader with extensive expertise in this area." Over the
coming months, Baumann will steer HealthCare's operating business together with
the HealthCare Executive Committee and will work on the strategic realignment
of the business in light of Bayer's future concentration on the Life Sciences
HealthCare and CropScience as announced.

Werner Baumann has been a member of the Board of Management of Bayer AG since
January 1, 2010. Effective October 1, 2014, he was appointed Chief Strategy and
Portfolio Officer (CSPO) with responsibility for Corporate Development and
Mergers & Acquisitions. He is also responsible for the Europe region. Prior to
October 1, 2014, he served as Bayer AG's Chief Financial Officer (CFO). Baumann
studied economics in Aachen and Cologne. He joined Bayer AG in 1988, where his
first duties were in the Corporate Finance Department. After holding positions
of increasing responsibility in Spain and the United States, he became a member
of the Board of Management of Bayer HealthCare.

Olivier Brandicourt has been Chairman of the Board of Management of Bayer
HealthCare AG and Chairman of the Bayer HealthCare Executive Committee since
November 1, 2013. He was also appointed a member of the Executive Council of
Bayer AG. Brandicourt studied medicine and biology in Paris and has worked as a
practicing physician. Having begun his industrial career in 1987 at Parke-Davis
/ Warner-Lambert, he subsequently joined Pfizer, where he held positions of
increasing responsibility, becoming a member of its Executive Leadership Team
in 2010.

Find more information at www.bayer.com.

Forward-looking statements

This release may contain forward-looking statements based on current
assumptions and forecasts made by Bayer Group or subgroup management. Various
known and unknown risks, uncertainties and other factors could lead to material
differences between the actual future results, financial situation, development
or performance of the company and the estimates given here. These factors
include those discussed in Bayer's public reports which are available on the
Bayer website at www.bayer.com. The company assumes no liability whatsoever to
update these forward-looking statements or to conform them to future events or